Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1991
07/03/1991CN1052669A Chroman and thiochroman derivatives
07/03/1991CN1052668A Compounds for treating inflammatory bowel disease
07/03/1991CN1052667A 唑衍生物  derivatives
07/03/1991CN1052664A Antithrombotic compounds
07/03/1991CN1052659A Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures
07/03/1991CN1052607A Cell cycle-dependent regulation of phosphorylation of human retion blastoma gene product
07/03/1991CN1013037B Process for the mfr. of novel triazolopyrimidine
07/03/1991CA2033363A1 Quinazoline derivatives and their preparation
07/02/1991US5028733 Prostaglandins
07/02/1991US5028730 Antihypercholesterolemic nitrile compounds
07/02/1991US5028727 Platinum-(IV)-diamine complex
07/02/1991US5028711 Hypotensive Agents
07/02/1991US5028698 Cytorhodin S derivatives and a process for their preparation
07/02/1991US5028664 Drug-release controlling coating material for long acting formulations
07/02/1991US5028630 Benzylamines
07/02/1991US5028628 Methods of treating pulmonary hypertension
07/02/1991US5028627 Controlling blood pressure during chemotherapy
07/02/1991US5028625 Chewable Tablet For Oral Administration
07/02/1991US5028624 Treatment of glaucoma
07/02/1991US5028622 Administration of amino acids as treatment for neurodegenerative disorders
07/02/1991US5028621 Drugs comprising porphyrins
07/02/1991US5028620 Biocide composition
07/02/1991US5028617 Livestock, controlling obesity in humans
07/02/1991US5028615 Quinoline derivatives as antagonists of leukotriene D4
07/02/1991US5028614 Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors
07/02/1991US5028612 Method for treating emotional numbness
07/02/1991US5028611 Treatment for cocaine use
07/02/1991US5028609 Alkyl diamine derivatives
07/02/1991US5028607 Bis(aryl)alkene compounds
07/02/1991US5028605 Antispasmodic, bronchodilators, uterine relaxants, cardiac analeptics, neurosedatives
07/02/1991US5028603 Platelet-Activating Factor Antagonist; Useful In Treatment Of Inflammatory Diseases, Allergic Diseases, Asthma, Respiratory System Disorders
07/02/1991US5028602 Thieno-(3,4-d)azepines, central nervous system disorders
07/02/1991US5028600 Novel pharmaceutical composition
07/02/1991US5028599 Injecting An Ethylene Oxide-Propylene Oxide Surfactant
07/02/1991US5028598 Viricides, treatment of AIDS
07/02/1991US5028595 Administering 2',3'-Dideoxycytidine
07/02/1991US5028536 Antitumor antibiotic BMY-41339
07/02/1991US5028439 Inhibition of parathyroid hormone secretion
07/02/1991US5028437 Treatment of animal diarrhoea
07/02/1991US5028434 Drug Delivery
07/02/1991US5028433 Readily absorbable drug formulation of NB-818
07/02/1991US5028432 Nonaqueous Matrix of Glyceride and/or Mineral Oil or Paraffin
07/02/1991US5028431 Antidermatitis substance
07/02/1991US5028427 Antibiotic
07/02/1991US5028411 Pharmaceutical compositions
07/02/1991CA1285575C Naphthalene anti-psoriatic agents
07/02/1991CA1285572C Di-t-butylphenol compounds
07/02/1991CA1285570C 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
07/02/1991CA1285569C 7-oxabicycloheptane substituted amide-thioamide prostalglandin analogs
07/02/1991CA1285566C 2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-isoquinoline compounds
07/02/1991CA1285565C 4-cyano-2,3,5,6,7,8-hexahydro-3-oxo-isoquinoline compounds
07/02/1991CA1285564C 1-heteroaryl-4-¬(2,5-pyrrolidinedion-1-yl)alkyl|piperazine derivatives
07/02/1991CA1285563C Ureidoalkanoylaminocarbonyl amino and imino acids and esters
07/02/1991CA1285562C Quinone derivatives, their production and use
07/02/1991CA1285561C Naphthoxazines
07/02/1991CA1285560C Derivatives of guanine
07/02/1991CA1285554C Method for preparing crystalline cefadroxil monohydrate
07/02/1991CA1285528C Preparation of electrolyte solutions and containers
07/02/1991CA1285491C Method of treating catabolic dysfunction
07/02/1991CA1285489C Process for the preparation of stabilized isosorbide- 5-mononitrate tablets, being also of sustained release, and formulations thus obtained
07/02/1991CA1285488C Pharmaceutical formulation containing indomethacin
07/02/1991CA1285487C Stable solid preparation of thiol ester derivative
07/02/1991CA1285486C Method for production of stable nicorandil preparation
07/02/1991CA1285485C Nicorandil-containing preparation for injection
07/02/1991CA1285484C Chlorpheniramine therapy
07/02/1991CA1285482C Sustained-release pharmaceutical preparation
06/1991
06/30/1991WO1991009857A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications
06/30/1991CA2222658A1 Intermediates in preparation of new phenylethanolaminomethyltetralins
06/30/1991CA2032289A1 Substituted 5-(alkyl) carboxamide imidazoles
06/30/1991CA2031479A1 Chroman esters of phenols and benzoic acids having retinoid-like activity
06/29/1991WO1991009594A1 Sigma receptor ligands and the use thereof
06/29/1991CA2071897A1 Sigma receptor ligands and the use thereof
06/29/1991CA2033303A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapeutics
06/29/1991CA2033121A1 Diaza compounds
06/29/1991CA2032251A1 Cyclopropyl derivative lipoxygenase inhibitors
06/29/1991CA2031469A1 Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension
06/28/1991WO1991009859A1 New xanthine derivatives
06/28/1991WO1991009611A1 Drug for preventing and treating fish diseases
06/28/1991CA2072602A1 Drug for preventing and treating fish diseases
06/28/1991CA2033118A1 Intravenous solutions for status epileptious
06/28/1991CA2032974A1 Process for the preparation of glycosylanthracyclinones
06/28/1991CA2032973A1 Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments
06/28/1991CA2032972A1 Benzanthracene compound and a process for preparing the same
06/28/1991CA2032885A1 Substituted 3,4-annelated benzimidazol-2(1h)-ones
06/27/1991WO1991009831A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
06/27/1991WO1991009114A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product
06/27/1991WO1991009056A1 Octapeptide analogs of somatostatin having threonine at the sixth position
06/27/1991WO1991009046A1 Morpholinyl derivatives of doxorubicin and process for their preparation
06/27/1991WO1991009038A1 Cephalosporins, processes for their preparation, intermediates and pharmaceutical compositions containing them
06/27/1991WO1991009020A2 PRODUCTION OF 5-(4'-HYDROXYPHENYL)HYDANTOIN AND D-p-HYDROXYPHENYLGLYCINE FROM 4-HYDROXYACETOPHENONE
06/27/1991WO1991009019A1 Substituted oxophthalazinyl acetic acids and analogs thereof
06/27/1991WO1991009017A1 Quinoline derivatives, their production and use
06/27/1991WO1991008746A1 Killing of activated lymphocytes
06/27/1991WO1991008745A1 Compositions and methods for preventing and treating rotaviral infections
06/27/1991WO1991008743A1 Circumvention of human tumor drug resistance
06/27/1991WO1991008742A1 Treatment of tremor using calcium-current-depressing compounds
06/27/1991WO1991008741A1 Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways
06/27/1991WO1991008740A1 The use of gaba-b selective agonists as anti-tussive agents
06/27/1991WO1991008735A1 Pharmaceutical preparations
06/27/1991WO1991008667A1 Inhibitors of pneumocystis carinii dihydrofolate reductase